ESCAPE Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. We are passionate about making a meaningful clinical impact for patients suffering from CNS diseases and believe in a genetically defined approach to achieving this goal

Biotechnology

ESCAPE Bio

ESCAPE Bio's headquarters in South San Francisco, CA, United States

Julie Anne Smith

Paul Wren

Carrolee Barlow

Anthony M. Rimac

Laura Brass

Peter Moldt

Scott Morrison

Edward Owens

Peter Thompson

R. Sanders Williams

The Leadership Team at ESCAPE Bio is responsible for setting the strategic direction and vision for the company, ensuring alignment across research, clinical development, and financial operations. This cohesive team of executives collaborates to steer the organization towards advancing innovative therapies for neurodegenerative diseases, while fostering a culture of scientific excellence and operational efficiency. Through their collective expertise, they drive decision-making and resource allocation to achieve impactful clinical outcomes for patients.

Leadership Team

The Clinical Operations and Research team at ESCAPE Bio is responsible for designing, implementing, and overseeing clinical trials to evaluate the efficacy and safety of new therapies for genetically defined neurodegenerative diseases. This includes managing trial logistics, ensuring regulatory compliance, and maintaining high-quality standards throughout the research process to make a meaningful clinical impact for patients suffering from CNS diseases.

ESCAPE Bio

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Research

Offices

ESCAPE Bio

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Research

Offices

Related companies